Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 6

Bosutinib: a SRC–ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia

Total article views   HTML views PDF downloads Totals
12,716 Dovepress* 10,328+ 2,099 12,427
PubMed Central* 2,388 1,032 3,420
Totals 12,716 3,131 15,847
*Since 5 August 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed and Google Scholar